On amoxicillin compounding, APC urges—and FDA acts
At APC’s urging, FDA has released a final guidance document stipulating minimum steps pharmacies that compound beta lactam oral antibiotic suspension products must take...
At APC’s urging, FDA has released a final guidance document stipulating minimum steps pharmacies that compound beta lactam oral antibiotic suspension products must take...
2023 is coming, and with it, new opportunities for you to serve and advance your profession. One of those opportunities is for you to lend your expertise as a member of a 2023 APC volunteer committee.
Agency issues guidance on beta lactam compounding in shortage
The start of cold and flu season has led to an immense spike in respiratory illness and also a shortage of amoxicillin oral suspension.
APC Board Chair-Elect Anthony Grzib spoke on behalf of APC during the open comment period of the Delaware Board of Pharmacy meeting on Wednesday November 16.
Please join us in welcoming the Pharmacy Compounding Foundation's 2023 Board of Directors.
Earlier this week, APC and two dozen other independent business organizations signed a letter to Congressional leaders, urging them to prioritize an antitrust bill that targets tech giants during the lame-duck session.
Speaker Nat Jones, RPh, FAPC, will show attendees how to identify and use medical research to help you better help your patients.
You can join the ranks of the elite technicians...and we can show you how.
This week's DTE discussion with FDA made some progress, but there's more work to be done by compounders.